NEW YORK, Oct. 17 – Deltagen has appointed Jeanne Y. Jew as vice president of business development, the company said on Wednesday. She was also made a member of the firm's executive management committee.

“We are actively looking at drug candidates internally and externally and I am confident Ms. Jew will provide tremendous value to our expanded business development efforts," said William Matthews, president and CEO of the genomic-based biotechnology company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.